University Hospital of Bellvitge
Our consolidated research group involves mainly physicians who belong to two medical services of the Bellvitge Hospital: Microbiology and Infectious Diseases. Members of both services are working together synergistically in diagnosing and treating patients with infectious disorders as well as in teaching medical students and residents and in doing experimental, clinical and epidemiological research. Their research projects are founded by EU, Spanish research agencies, and scientific societies.
Our principal focus of research are:
To identify risk factors for colonization and infection due to drug-resistant Pseudomonas aeruginosa in order to identify predictors for the best empirical therapy.
To optimize clinical management of sepsis caused by MRSA.
To optimize the management of prosthetic-joint infections (PJI)caused by MDR bacteria.
To improve the prevention and empiric management of bacterial infections in transplant patients and in those patients with cancer.
To progress in the prevention of cytomegaloviruses diseases in transplant patients.
To study the pathogenesis of fungal infections in transplant patients and in those patients with cancer.
Main contributions, among others, have been the description of clinical outcomes and epidemiological features of MDR-bacterial infections in cancer and in transplant patients, specially those caused by ESBL-E.coli and ESKAPE microorganisms, optimizing empirical treatment of MDR-Pseudomonas aeruginosa infections, detailing host-pathogen interaction genomics, transcriptomics and proteomics and risk factors for patients with fungal infections, or improving the management of prosthetic joint infections. Overall, the group has nearly 250 publications in the last five years.
Dr. Jordi Carratalá